Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Candidiasis, Invasive”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02163889
What this trial is testing

Serial Therapeutic and Antifungal Monitoring Protocol

Who this might be right for
Candidemia
T2 Biosystems 31
Not applicableStudy completedNCT01047267
What this trial is testing

Pharmacokinetics of Anidulafungin on Intensive Care Unit (ICU)

Who this might be right for
Invasive CandidiasisCritically Ill
University Medical Center Groningen 20
Large-scale testing (Phase 3)Study completedNCT00761267
What this trial is testing

Study To Assess Pharmacokinetics, Safety & Efficacy of Anidulafungin When Treating Children With Invasive Candidiasis

Who this might be right for
Candidemia
Pfizer 70
Not applicableStudy completedNCT02801682
What this trial is testing

NOBICS - NOvel BIomarker In Invasive CandidiasiS/Candida Sepsis

Who this might be right for
Invasive Candidiasis
Medical University of Graz 200
Large-scale testing (Phase 3)Study completedNCT04368559
What this trial is testing

Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation

Who this might be right for
CandidemiaMycosesFungal Infection+7 more
Mundipharma Research Limited 602
Large-scale testing (Phase 3)Study completedNCT00001937
What this trial is testing

Comparing the Effectiveness of Fluconazole and a New Medicine (FK463) in Preventing Fungal Infections in Bone Marrow Transplant Patients

Who this might be right for
AspergillosisCandidiasisFungemia+1 more
National Cancer Institute (NCI) 800
Testing effectiveness (Phase 2)Study completedNCT00739934
What this trial is testing

Study Of The Pharmacokinetics And Safety Of Voriconazole In Children 2 To 11 Years Old Who Are At High Risk For Systemic Fungal Infection

Who this might be right for
CandidiasisCandidemia
Pfizer 40
Post-approval studies (Phase 4)Study completedNCT00647907
What this trial is testing

The Efficacy and Safety of Voriconazole for the Treatment of Fungal Infections

Who this might be right for
CandidiasisCryptococcosisAspergillosis
Pfizer 7
Testing effectiveness (Phase 2)Study completedNCT03604705
What this trial is testing

An Efficacy and Safety Study of APX001 in Non-Neutropenic Patients With Candidemia

Who this might be right for
Candidemia
Basilea Pharmaceutica 21
Early research (Phase 1)Study completedNCT01666769
What this trial is testing

Pharmacokinetics of Micafungin in Children on Extracorporeal Membrane Oxygenation

Who this might be right for
Invasive Candidiasis
Kevin Watt 18
Not applicableStudy completedNCT04874441
What this trial is testing

Candida PCR Diagnosis Strategy in Patients From Intensive Care Units

Who this might be right for
Candida
University Hospital, Toulouse 48
Post-approval studies (Phase 4)Study completedNCT00670657
What this trial is testing

CRITIC - Treatment of Candidemia and Invasive Candidiasis

Who this might be right for
CandidemiaInvasive Candidiasis
Gilead Sciences 39
Post-approval studies (Phase 4)Study completedNCT00001107
What this trial is testing

Comparison of Two Treatments to Prevent Invasive Fungal Infections in Patients Who Have Received Liver Transplants

Who this might be right for
Candidiasis
National Institute of Allergy and Infectious Diseases (NIAID) 500
Testing effectiveness (Phase 2)Study completedNCT02734862
What this trial is testing

CD101 Compared to Caspofungin Followed by Oral Step Down in Subjects With Candidemia and/or Invasive Candidiasis-Bridging Extension

Who this might be right for
CandidemiaMycosesFungal Infection+2 more
Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 207
Not applicableLooking for participantsNCT01386437
What this trial is testing

Natural History of Individuals With Immune System Problems That Lead to Fungal Infections

Who this might be right for
Chronic Mucocutaneous CandidiasisInvasive AspergillosisCARD9+1 more
National Institute of Allergy and Infectious Diseases (NIAID) 1,200
Testing effectiveness (Phase 2)Ended earlyNCT01945281
What this trial is testing

Safety, Tolerability, and Efficacy of Caspofungin Versus Amphotericin B Deoxycholate in the Treatment of Invasive Candidiasis in Neonates and Infants (MK-0991-064)

Who this might be right for
Candidiasis, Invasive
Merck Sharp & Dohme LLC 51
Large-scale testing (Phase 3)Not Yet RecruitingNCT06859671
What this trial is testing

Study of a Short Duration Therapy for Candidemia

Who this might be right for
CANDIDEMIA
Assistance Publique - Hôpitaux de Paris 362
Post-approval studies (Phase 4)Study completedNCT00520234
What this trial is testing

Randomized Study of Caspofungin Prophylaxis Followed by Pre-emptive Therapy for Invasive Candidiasis in the Intensive Care Unit (ICU)

Who this might be right for
Invasive Candidiasis
Mycoses Study Group 222
Post-approval studies (Phase 4)Not Yet RecruitingNCT07788586
What this trial is testing

Shortening Treatment Duration in Uncomplicated Candidemia: the CanTEN Trial

Who this might be right for
CandidemiaInvasive Candidiasis
Oliver Cornely, MD 420
Post-approval studies (Phase 4)Study completedNCT04122560
What this trial is testing

Fluconazole Pharmacokinetics, Including Bioavailability, in Obese Subjects After an Intravenous and Oral Administration

Who this might be right for
FluconazoleCandidiasisInvasive Fungal Infections+1 more
Radboud University Medical Center 25
Next Page